肺癌中ALK重组与超晚复发之间的关联:病例报告和聚合分析

Jamila Mammadova1, Tawee Tanvetyanon2

  • 1Department of Hematology and Oncology, University of South Florida, Tampa, USA.

Cureus
|January 31, 2024
PubMed
概括

非小细胞肺癌 (NSCLC) 的超晚复发很罕见. 在对27例病例的综合分析中,鉴定出无性淋巴瘤激酶 (ALK) 重组是导致复发时间的唯一显著预测因素.